Implantable Defibrillators Configured for Hybrid Therapy of Persistent and Permanent Atrial Fibrillation: Initial Clinical Experience with a Novel Lead System∗
- 54 Downloads
Aim: Hybrid therapy strategies have combined antiarrhythmic drugs (AAD) with pacemakers, atrio-ventricular defibrillators (AV ICD) or atrial ablation individually. The feasibility combining AAD with dual site RA pacing (DAP) in an AV ICD has not been examined.
Methods: We used an AV ICD with a novel lead configuration permitting DAP, antitachycardia pacing (ATP) or atrial shocks (ADF) in patients (pts) with refractory persistent or permanent AF. Hybrid therapy included linear RA ablation and/or focal ablation. Continuous DAP and automatic ATP with patient or physician activated ADF.
Results: 24 pts, mean age 66 ± 10 yrs, with cardiac disease (22 pts), underwent insertion of an AVICD with dual RA leads. 20 patients had concomitant ablative procedures (RA only = 19, RA + LA = 1) and all pts continued previously ineffective AAD. During a follow-up of 2–36 months (mean 17 ± 8 mos), rhythm control was restored in all pts & maintained long-term in 19 (83%) pts. 8 pts used AF termination therapies successfully. Device datalogs showed no episodes of AF in 6 pts, asymptomatic brief arrhythmias in 4 pts, infrequent paroxysmal AF in 9 pts & persistent AF recurred in 5 pts. AV ICD detection algorithms reliably detected AF or AT in the DAP mode in all pts. Intermittent brief P wave double counting occurred during AT in selected pts. No pt received inappropriate ADF therapy.
Conclusions: 1. DAP can be safely incorporated in an AVICD devices for use in an hybrid therapy strategy for AF pts. 2. These devices can be effective for both AF prevention & termination. 3. Long term rhythm control can be achieved and documented by device datalogs in persistent and permanent AF.
Keywordsmultisite pacing atrial fibrillation tachycardias implantable defibrillators therapy of arrhythmias hybrid therapy
Unable to display preview. Download preview PDF.
- 1.Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347(23):1834–1840.CrossRefPubMedGoogle Scholar
- 2.Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, et al. STAF Investigators. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003;41:1690–1696.CrossRefPubMedGoogle Scholar
- 5.Domanski MJ, Zipes DP, Benditt DG, Camm AJ, Exner DV, Ezekowitz MD, Greene HL, Lesh MD, Miller JM, Pratt CM, Saksena S, Scheinman MM, Singh BN, Tracy CM, Waldo AL: Central clinical research issues in electrophysiology: report of the NASPE Committee. Pacing Clin Electrophysiol 2001;24(4 Pt 1):526–534.CrossRefPubMedGoogle Scholar
- 13.Fuster V, Ryden LE, Asinger RW, Cannom DS etal., ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American college of Cardiology/American Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. J Am Coll Cardiol 2001;38:1231–1266.CrossRefPubMedGoogle Scholar
- 14.Saksena S, Skadsberg N, Rao BH, Filipecki A, Biatrial and 3-Dimensional Mapping of Spontaneous Atrial Arrhythmias in Patients with Refractory Atrial Fibrillation. J Cardiovasc Electrophysiol May 2005 (in press).Google Scholar
- 15.Schimtt C, Montero M, Melicherick J, Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. Pacing Clin Electrophysiol 1998;17:295–302.Google Scholar
- 16.Lee MA, Weachter R, Pollak S, Kremers MS, Naik AM, Silverman R, Tuzi J, Wang W, Johnson LJ, Euler DE, ATTEST Investigators. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: Results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 2003;41(11):1926–1932.CrossRefPubMedGoogle Scholar